AUB ScholarWorks

Vascular endothelial growth factor family of ligands and receptors: Review

Show simple item record

dc.contributor.author Otrock Z.K.
dc.contributor.author Makarem J.A.
dc.contributor.author Shamseddine A.I.
dc.contributor.editor
dc.date May-2007
dc.date.accessioned 2017-10-05T15:37:26Z
dc.date.available 2017-10-05T15:37:26Z
dc.date.issued 2007
dc.identifier 10.1016/j.bcmd.2006.12.003
dc.identifier.isbn
dc.identifier.issn 10799796
dc.identifier.uri http://hdl.handle.net/10938/15715
dc.description.abstract VEGF signaling often represents a critical rate-limiting step in physiological angiogenesis. The VEGF family comprises seven secreted glycoproteins that are designated VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, placental growth factor (PlGF) and VEGF-F. The VEGF family members bind their cognate receptors. The receptors identified so far are designated VEGFR-1, VEGFR-2, VEGFR-3 and the neuropilins (NP-1 and NP-2). We review in this article the biology of the VEGF ligands and the receptors. © 2007 Elsevier Inc. All rights reserved.
dc.format.extent
dc.format.extent Pages: (258-268)
dc.language English
dc.publisher SAN DIEGO
dc.relation.ispartof Publication Name: Blood Cells, Molecules, and Diseases; Publication Year: 2007; Volume: 38; no. 3; Pages: (258-268);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Vascular endothelial growth factor family of ligands and receptors: Review
dc.type Review
dc.contributor.affiliation Otrock, Z.K., Division of Hematology-Oncology, Department of Internal Medicine, American University, P.O. Box: 113-6044, Beirut 1107 2802, Lebanon
dc.contributor.affiliation Makarem, J.A., Division of Hematology-Oncology, Department of Internal Medicine, American University, P.O. Box: 113-6044, Beirut 1107 2802, Lebanon
dc.contributor.affiliation Shamseddine, A.I., Division of Hematology-Oncology, Department of Internal Medicine, American University, P.O. Box: 113-6044, Beirut 1107 2802, Lebanon
dc.contributor.authorAddress Shamseddine, A.I.; Division of Hematology-Oncology, Department of Internal Medicine, American University, P.O. Box: 113-6044, Beirut 1107 2802, Lebanon; email: as04@aub.edu.lb
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; Division: Hematology-Oncology;
dc.contributor.authorDepartment Internal Medicine
dc.contributor.authorDivision Hematology-Oncology
dc.contributor.authorEmail as04@aub.edu.lb
dc.contributor.faculty Faculty of Medicine
dc.contributor.authorInitials Otrock, ZK
dc.contributor.authorInitials Makarem, JA
dc.contributor.authorInitials Shamseddine, AI
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Shamseddine, AI (reprint author), Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Hematol Oncol, POB 113-6044, Beirut 1107 2802, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Abraham D, 2000, CIRC RES, V87, P644; Achen MG, 2001, J PATHOL, V193, P147, DOI 10.1002-1096-9896(2000)9999:9999::AID-PATH7573.0.CO;2-G; Akahane M, 2006, INT J CANCER, V118, P841, DOI 10.1002-ijc.21420; Asano A, 1999, J VET MED SCI, V61, P403, DOI 10.1292-jvms.61.403; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038-nm884; Baffert F, 2004, CIRC RES, V94, P984, DOI 10.1161-01.RES.0000125295.43813.1F; Bagri A, 2002, ADV EXP MED BIOL, V515, P13; Barleon B, 1996, BLOOD, V87, P3336; Bellomo D, 2000, CIRC RES, V86, P29; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073-pnas.94.16.8761; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016-j.yexcr.2005.11.024; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084-jem.176.5.1375; Byzova TV, 2002, BLOOD, V99, P4434, DOI 10.1182-blood.V99.12.4434; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038-380435a0; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038-87904; Chen L, 2004, NAT MED, V10, P813, DOI 10.1038-nm1078; Chen WS, 2002, IN VIVO, V16, P439; Chilov D, 1997, J BIOL CHEM, V272, P25176, DOI 10.1074-jbc.272.40.25176; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074-jbc.M313237200; Clauss M, 1996, J BIOL CHEM, V271, P17629; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016-S0968-0004(03)00193-2; Dalal S, 2005, CLIN CANCER RES, V11, P2364, DOI 10.1158-1078-0432.CCR-04-1201; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200-JCO.2002.10.088; Enholm B, 2001, CIRC RES, V88, P623; Enholm B, 1997, ONCOGENE, V14, P2475, DOI 10.1038-sj.onc.1201090; Farnebo F, 1999, BIOCHEM BIOPH RES CO, V257, P891, DOI 10.1006-bbrc.1999.0562; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038-nrc909; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038-nm0603-669; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210-er.2003-0027; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053-sonc.2002.37264; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038-376066a0; Fuh G, 2000, J BIOL CHEM, V275, P26690; Fujimoto J, 2004, BRIT J CANCER, V91, P466, DOI 10.1038-sj.bjc.6601963; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073-pnas.040337597; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074-jbc.273.46.30336; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074-jbc.272.38.23659; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074-jbc.273.21.13313; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074-jbc.M002016200; Grimmond S, 1996, GENOME RES, V6, P124, DOI 10.1101-gr.6.2.124; Gupta K, 2005, POSTGRAD MED J, V81, P236, DOI 10.1136-pgmj.2004.023309; Hachisuka T, 2005, ONCOL REP, V13, P733; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038-740; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158-0008-5472.CAN-04-4576; He YL, 2004, BBA-REV CANCER, V1654, P3, DOI 10.1016-j.bbcan.2003.07.003; Herzog Y, 2001, MECH DEVELOP, V109, P115, DOI 10.1016-S0925-4773(01)00518-4; Hood JD, 1998, AM J PHYSIOL, V274, P1054; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806; Hughes DC, 2001, J MOL EVOL, V53, P77; Ikai T, 2005, EUR J HAEMATOL, V75, P273, DOI 10.1111-j.1600-0609.2005.00505.x; Ishii H, 2004, LUNG CANCER-J IASLC, V45, P325, DOI 10.1016-j.lungcan.2004.02.021; JAKEMAN LB, 1993, ENDOCRINOLOGY, V133, P848, DOI 10.1210-en.133.2.848; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126-science.276.5317.1423; Jennbacken K, 2005, PROSTATE, V65, P110, DOI 10.1002-pros.20276; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093-emboj-16.13.3898; Kabrun N, 1997, DEVELOPMENT, V124, P2039; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038-ni1013; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073-pnas.221449198; Karkkainen MJ, 2000, NAT GENET, V25, P153; Kawakami M, 2003, J EXP CLIN CANC RES, V22, P229; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073-pnas.90.22.10705; Kiba A, 2003, J BIOL CHEM, V278, P13453, DOI 10.1074-jbc.M210931200; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; KLAGSBRUN M, 1991, PEPTIDE GROWTH FACTO, P549; Klagsbrun M, 2002, ADV EXP MED BIOL, V515, P33; Kleespies A, 2005, ONKOLOGIE, V28, P281, DOI 10.1159-000085198; Kukk E, 1996, DEVELOPMENT, V122, P3829; Lamszus K, 2003, CLIN CANCER RES, V9, P1399; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038-sj.onc.1201928; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126-science.1079562; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126-science.2479986; Li J, 2005, INT J RADIAT ONCOL, V62, P1477, DOI 10.1016-j.ijrobp.2005.04.028; Liu J, 2005, MED ONCOL, V22, P389, DOI 10.1385-MO:22:4:389; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038-nm731; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038-nm1101-1194; Lymboussaki A, 1999, CIRC RES, V85, P992; LYTTLE DJ, 1994, J VIROL, V68, P84; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093-emboj-20.4.672; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126-stke.2001.112.re21; MATTHEWS W, 1991, P NATL ACAD SCI USA, V88, P9026, DOI 10.1073-pnas.88.20.9026; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093-emboj-18.2.363; Miao HQ, 2000, CANCER METAST REV, V19, P29, DOI 10.1023-A:1026579711033; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016-0092-8674(93)90573-9; Mould AW, 2003, ARTHRITIS RHEUM, V48, P2660, DOI 10.1002--art.11232; Nagy JA, 2003, TRENDS CARDIOVAS MED, V13, P169, DOI 10.1016-S1050-1738(03)00056-2; Nash AD, 2006, PULM PHARMACOL THER, V19, P61, DOI 10.1016-j.pupt.2005.02.007; Neufeld G, 1999, FASEB J, V13, P9; Neufeld Gera, 1994, Progress in Growth Factor Research, V5, P89, DOI 10.1016-0955-2235(94)90019-1; Nilsson I, 2004, FASEB J, V18, P1507, DOI 10.1096-fj.03-1276com; Nishi M, 2005, INT J ONCOL, V26, P1517; Odorisio T, 2002, J CELL SCI, V115, P2559; Ogawa S, 1998, J BIOL CHEM, V273, P31273, DOI 10.1074-jbc.273.47.31273; Olofsson B, 1996, J BIOL CHEM, V271, P19310; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073-pnas.93.6.2576; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182-blood-2002-05-1516; Paavonen K, 2000, AM J PATHOL, V156, P1499, DOI 10.1016-S0002-9440(10)65021-3; Paavonen K, 1996, CIRCULATION, V93, P1079; PAJUSOLA K, 1994, ONCOGENE, V9, P3545; PARK JE, 1994, J BIOL CHEM, V269, P25646; Partanen TA, 1999, CANCER, V86, P2406, DOI 10.1002-(SICI)1097-0142(19991201)86:112406::AID-CNCR313.0.CO;2-E; PERSICO MG, 1999, VASCULAR GROWTH FACT, P31; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073-pnas.90.19.8915; Pipp F, 2003, CIRC RES, V92, P378, DOI 10.1161-01.RES.0000057997.77714.72; Rini BI, 2005, J CLIN ONCOL, V23, P1028, DOI 10.1200-JCO.2005.01.186; Risau W, 1997, NATURE, V386, P671; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161-01.RES.0000073584-46059.E3; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074-jbc.273.14.8413; Rossiter H, 2004, CANCER RES, V64, P3508, DOI 10.1158-0008-5472.CAN-03-2581; Saaristo A, 2002, FASEB J, V16, P1041, DOI 10.1096-fj.01-1042com; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016-j.it.2004.05.003; Salven P, 1998, AM J PATHOL, V153, P103, DOI 10.1016-S0002-9440(10)65550-2; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016-S0002-9440(10)64255-1; Scotney PD, 2002, CLIN EXP PHARMACOL P, V29, P1024, DOI 10.1046-j.1440-1681.2002.03769.x; Selvaraj SK, 2003, BLOOD, V102, P1515, DOI 10.1182-blood-2002-11-3423; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126-science.6823562; Sheen IS, 2005, WORLD J GASTROENTERO, V11, P187; SHIBUYA M, 1990, ONCOGENE, V5, P519; SHWEIKI D, 1993, J CLIN INVEST, V91, P2235, DOI 10.1172-JCI116450; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172-JCI200317220; Silins G, 1997, BIOCHEM BIOPH RES CO, V230, P413, DOI 10.1006-bbrc.1996.5979; Silvestre JS, 2003, CIRC RES, V93, P114, DOI 10.1161-01.RES.0000081594.21764.44; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016-S0002-9440(10)61765-8; Soker S, 1998, CELL, V92, P735, DOI 10.1016-S0092-8674(00)81402-6; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038-84635; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002-bies.20092; Suto K, 2005, J BIOL CHEM, V280, P2126, DOI 10.1074-jbc.M411395200; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093-emboj-20.11.2768; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038-sj.onc.1201047; TERMAN BI, 1991, ONCOGENE, V6, P1677; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Toi M, 2002, INT J CANCER, V98, P14, DOI 10.1002-ijc.10121; Tordjman R, 1999, BLOOD, V94, P2301; Valtola R, 1999, AM J PATHOL, V154, P1381, DOI 10.1016-S0002-9440(10)65392-8; Veikkola T, 2003, FASEB J, V17, P2006, DOI 10.1096-fj.03-0179com; Von Marschall Z, 2005, INT J ONCOL, V27, P669; Vosseler S, 2005, CANCER RES, V65, P1294, DOI 10.1158-0008-5472.CAN-03-3986; Wei SC, 2005, GUT, V54, P666, DOI 10.1136-gut.2004.050831; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016-S0092-8674(00)80456-0; Wise LM, 1999, P NATL ACAD SCI USA, V96, P3071, DOI 10.1073-pnas.96.6.3071; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182-blood-2002-12-3793; Yamazaki Y, 2005, BIOCHEMISTRY-US, V44, P8858, DOI 10.1021-bi050197d; Yuan L, 2002, DEVELOPMENT, V129, P4797; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016-S0008-6363(00)00268-6
dc.description.citedCount 145
dc.description.citedTotWOSCount 149
dc.description.citedWOSCount 129
dc.format.extentCount 11
dc.identifier.articleNo
dc.identifier.coden BCMDF
dc.identifier.pubmedID 17344076
dc.identifier.scopusID 34047141776
dc.identifier.url
dc.publisher.address 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Blood Cells Mol. Dis.
dc.relation.ispartOfIssue 3
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Blood Cells, Molecules, and Diseases
dc.relation.ispartofPubTitleAbbr Blood Cells Mol. Dis.
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 38
dc.source.ID WOS:000245785100011
dc.type.publication Journal
dc.subject.otherAuthKeyword Angiogenesis
dc.subject.otherAuthKeyword Ligand
dc.subject.otherAuthKeyword Receptor
dc.subject.otherAuthKeyword Review
dc.subject.otherAuthKeyword Vascular endothelial growth factor
dc.subject.otherChemCAS neuropilin 1, 214210-47-6, 339035-30-2
dc.subject.otherChemCAS neuropilin 2, 227018-38-4
dc.subject.otherChemCAS vasculotropin, 127464-60-2
dc.subject.otherChemCAS vasculotropin A, 489395-96-2
dc.subject.otherChemCAS vasculotropin C, 171342-42-0, 185969-81-7
dc.subject.otherChemCAS vasculotropin D, 193363-12-1
dc.subject.otherChemCAS vasculotropin receptor, 301253-48-5
dc.subject.otherChemCAS Ligands
dc.subject.otherChemCAS Receptors, Vascular Endothelial Growth Factor, 2.7.1.112
dc.subject.otherChemCAS Vascular Endothelial Growth Factors
dc.subject.otherIndex neuropilin 1
dc.subject.otherIndex neuropilin 2
dc.subject.otherIndex placental growth factor
dc.subject.otherIndex unclassified drug
dc.subject.otherIndex vasculotropin
dc.subject.otherIndex vasculotropin A
dc.subject.otherIndex vasculotropin B
dc.subject.otherIndex vasculotropin C
dc.subject.otherIndex vasculotropin D
dc.subject.otherIndex vasculotropin e
dc.subject.otherIndex vasculotropin F
dc.subject.otherIndex vasculotropin receptor
dc.subject.otherIndex vasculotropin receptor 1
dc.subject.otherIndex vasculotropin receptor 2
dc.subject.otherIndex vasculotropin receptor 3
dc.subject.otherIndex angiogenesis
dc.subject.otherIndex human
dc.subject.otherIndex ligand binding
dc.subject.otherIndex nonhuman
dc.subject.otherIndex priority journal
dc.subject.otherIndex protein family
dc.subject.otherIndex protein function
dc.subject.otherIndex protein protein interaction
dc.subject.otherIndex receptor binding
dc.subject.otherIndex review
dc.subject.otherIndex signal transduction
dc.subject.otherIndex Animals
dc.subject.otherIndex Humans
dc.subject.otherIndex Ligands
dc.subject.otherIndex Neovascularization, Pathologic
dc.subject.otherIndex Neovascularization, Physiologic
dc.subject.otherIndex Receptors, Vascular Endothelial Growth Factor
dc.subject.otherIndex Vascular Endothelial Growth Factors
dc.subject.otherKeywordPlus LYMPH-NODE METASTASIS
dc.subject.otherKeywordPlus B VEGF-B
dc.subject.otherKeywordPlus FACTOR-C
dc.subject.otherKeywordPlus TUMOR ANGIOGENESIS
dc.subject.otherKeywordPlus TYROSINE KINASE
dc.subject.otherKeywordPlus IN-VIVO
dc.subject.otherKeywordPlus FLT-1 RECEPTOR
dc.subject.otherKeywordPlus ORF VIRUS
dc.subject.otherKeywordPlus DEVELOPMENTAL EXPRESSION
dc.subject.otherKeywordPlus EPIDERMAL-KERATINOCYTES
dc.subject.otherWOS Hematology


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account